Use of Wharton Jelly in Diabetic Nephropathy

Clinical trial NCT03288571 · UNKNOWN

Trial details

NCT number: NCT03288571
Sponsor: Sophia Al-Adwan
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diabetic Nephropathies

Start date: 2019-11-01
Primary completion: 2020-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.